Skip to main content
(352) 733-0111

Clinical trials

Our exceptional foundation of physicians and state-of-the-art methods, like XVIVO and intensity-modulated radiation therapy, to diagnose and treat complex lung diseases makes pulmonology care a hallmark of UF Health.

Interstitial lung disease team
  • 1305-0014 (FIBRONEERTM IPF)

    This study is open to adults with a lung disease called Idiopathic Pulmonary Fibrosis (IPF). People can join the study if they are 40 years or older. If they already take nintedanib or pirfenidone for their IPF, they can continue treatment…

    Investigators
    Divya C Patel, Christopher Harden
    Ages
    40 Years - N/A
    Sexes
    All
  • 1305-0023 (FIBRONEERTM ILD)

    This study is open to adults with Progressive Fibrosing Interstitial Lung Diseases (PF-ILDs). People who have a form of PF-ILD other than Idiopathic Pulmonary Fibrosis (IPF) can join the study. If they already take nintedanib, they can continue…

    Investigators
    Divya C Patel, Christopher Harden
    Ages
    18 Years - N/A
    Sexes
    All